These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 27301784)
21. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium. Urlacher VB; Schmid RD Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074 [No Abstract] [Full Text] [Related]
22. Peroxygenases en route to becoming dream catalysts. What are the opportunities and challenges? Wang Y; Lan D; Durrani R; Hollmann F Curr Opin Chem Biol; 2017 Apr; 37():1-9. PubMed ID: 27992798 [TBL] [Abstract][Full Text] [Related]
26. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Otey CR; Bandara G; Lalonde J; Takahashi K; Arnold FH Biotechnol Bioeng; 2006 Feb; 93(3):494-9. PubMed ID: 16224788 [TBL] [Abstract][Full Text] [Related]
27. Recent developments in the application of P450 based biocatalysts. Wei Y; Ang EL; Zhao H Curr Opin Chem Biol; 2018 Apr; 43():1-7. PubMed ID: 29100098 [TBL] [Abstract][Full Text] [Related]
28. Advances in enzyme biocatalysis for the preparation of functional lipids. Zhang H; Secundo F; Sun J; Mao X Biotechnol Adv; 2022 Dec; 61():108036. PubMed ID: 36130694 [TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Urlacher VB; Girhard M Trends Biotechnol; 2012 Jan; 30(1):26-36. PubMed ID: 21782265 [TBL] [Abstract][Full Text] [Related]
30. The nature of chemical innovation: new enzymes by evolution. Arnold FH Q Rev Biophys; 2015 Nov; 48(4):404-10. PubMed ID: 26537398 [TBL] [Abstract][Full Text] [Related]
31. Protein engineering of stereoselective Baeyer-Villiger monooxygenases. Zhang ZG; Parra LP; Reetz MT Chemistry; 2012 Aug; 18(33):10160-72. PubMed ID: 22807240 [TBL] [Abstract][Full Text] [Related]
32. Catalytic C-H amination: a reaction now accessible to engineered natural enzymes. Mahy JP; Ciesielski J; Dauban P Angew Chem Int Ed Engl; 2014 Jul; 53(27):6862-4. PubMed ID: 24895319 [No Abstract] [Full Text] [Related]
33. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. Schroer K; Kittelmann M; Lütz S Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361 [TBL] [Abstract][Full Text] [Related]
34. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system. Lentz O; Feenstra A; Habicher T; Hauer B; Schmid RD; Urlacher VB Chembiochem; 2006 Feb; 7(2):345-50. PubMed ID: 16381045 [TBL] [Abstract][Full Text] [Related]
35. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution. Agudo R; Roiban GD; Reetz MT Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296 [TBL] [Abstract][Full Text] [Related]
37. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives. Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322 [TBL] [Abstract][Full Text] [Related]
38. Protein engineering of microbial enzymes. Böttcher D; Bornscheuer UT Curr Opin Microbiol; 2010 Jun; 13(3):274-82. PubMed ID: 20171138 [TBL] [Abstract][Full Text] [Related]
39. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities. Yun CH; Kim KH; Kim DH; Jung HC; Pan JG Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492 [TBL] [Abstract][Full Text] [Related]
40. Production of hydroxy fatty acids by microbial fatty acid-hydroxylation enzymes. Kim KR; Oh DK Biotechnol Adv; 2013 Dec; 31(8):1473-85. PubMed ID: 23860413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]